Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brooks Jackson

Showing results (51-60 of 134) with videos related to

Pageof 14
Sort By:
AIDS Research and Human Retroviruses|May 23, 2002
Identification of Ugandan HIV type 1 variants with unique patterns of recombination in pol involving subtypes A and DSusan H Eshleman, Matthew J Gonzales, Graziella Becker-Pergola, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 15, 2013
Long-term follow-up of children in the HIVNET 012 perinatal HIV prevention trial: five-year growth and survivalMaxensia Owor, Anthony Mwatha, Deborah Donnell, et al.
AIDS Research and Human Retroviruses|August 9, 2002
Analysis of length variation in the V1-V2 region of env in nonsubtype B HIV type 1 from UgandaAlexandra M Klevytska, Martin R Mracna, Laura Guay, et al.
ISRN Hematology|December 5, 2012
Implications of weight and body mass index for plasma donation and healthGenna A Jerrard, Jing Liu, Rosemary C Case, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 15, 2004
Characterization of nevirapine resistance mutations in women with subtype A vs. D HIV-1 6-8 weeks after single-dose nevirapine (HIVNET 012)Susan H Eshleman, Laura A Guay, Anthony Mwatha, et al.
AIDS Research and Human Retroviruses|September 16, 2008
Analysis of nevirapine resistance mutations in cloned HIV type 1 variants from HIV-infected Ugandan infants using a single-step amplification-sequencing method (AmpliSeq)William Ian Towler, Jessica D Church, James R Eshleman, et al.
Vaccines|April 27, 2026
A Cross-Sectional Survey on HPV Vaccination in a Houston HIV ClinicShailee R Modi, Erika S Fanous, Avery N Sinnathamby, et al.
AIDS (London, England)|September 22, 2007
Detection of K103N in Ugandan women after repeated exposure to single dose nevirapineTamara S Flys, Anthony Mwatha, Laura A Guay, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 20, 2002
Survival of Ugandan infants with subtype A and D HIV-1 infection (HIVNET 012)Susan H Eshleman, Laura A Guay, Thomas Fleming, et al.
The Journal of Infectious Diseases|January 31, 2007
Persistence of K103N-containing HIV-1 variants after single-dose nevirapine for prevention of HIV-1 mother-to-child transmissionTamara S Flys, Deborah Donnell, Anthony Mwatha, et al.
Pageof 14

Showing results (51-60 of 134) with videos related to

Sort By:
Pageof 14
AIDS Research and Human Retroviruses|May 23, 2002
Identification of Ugandan HIV type 1 variants with unique patterns of recombination in pol involving subtypes A and DSusan H Eshleman, Matthew J Gonzales, Graziella Becker-Pergola, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 15, 2013
Long-term follow-up of children in the HIVNET 012 perinatal HIV prevention trial: five-year growth and survivalMaxensia Owor, Anthony Mwatha, Deborah Donnell, et al.
AIDS Research and Human Retroviruses|August 9, 2002
Analysis of length variation in the V1-V2 region of env in nonsubtype B HIV type 1 from UgandaAlexandra M Klevytska, Martin R Mracna, Laura Guay, et al.
ISRN Hematology|December 5, 2012
Implications of weight and body mass index for plasma donation and healthGenna A Jerrard, Jing Liu, Rosemary C Case, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 15, 2004
Characterization of nevirapine resistance mutations in women with subtype A vs. D HIV-1 6-8 weeks after single-dose nevirapine (HIVNET 012)Susan H Eshleman, Laura A Guay, Anthony Mwatha, et al.
AIDS Research and Human Retroviruses|September 16, 2008
Analysis of nevirapine resistance mutations in cloned HIV type 1 variants from HIV-infected Ugandan infants using a single-step amplification-sequencing method (AmpliSeq)William Ian Towler, Jessica D Church, James R Eshleman, et al.
Vaccines|April 27, 2026
A Cross-Sectional Survey on HPV Vaccination in a Houston HIV ClinicShailee R Modi, Erika S Fanous, Avery N Sinnathamby, et al.
AIDS (London, England)|September 22, 2007
Detection of K103N in Ugandan women after repeated exposure to single dose nevirapineTamara S Flys, Anthony Mwatha, Laura A Guay, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 20, 2002
Survival of Ugandan infants with subtype A and D HIV-1 infection (HIVNET 012)Susan H Eshleman, Laura A Guay, Thomas Fleming, et al.
The Journal of Infectious Diseases|January 31, 2007
Persistence of K103N-containing HIV-1 variants after single-dose nevirapine for prevention of HIV-1 mother-to-child transmissionTamara S Flys, Deborah Donnell, Anthony Mwatha, et al.
Pageof 14